Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-04-23 | Suzanne Blaug, age 62, has more than 30 years of strategic and commercial experience in the biopharmaceutical industry. ... Ms. Blaug became a member of the compensation committee and nominating and corporate governance committee on September 5, 2019. |
| 2022-04-29 | Suzanne Blaug, age 64, has more than 30 years of strategic and commercial experience in the biopharmaceutical industry... Ms. Blaug became Chair of the compensation Committee on May 26, 2021... Ms. Blaug is on Audit, Compensation (Chair), and Nominating and Corporate Governance committees... Total compensation in 2021 was $255,561. |
| 2023-04-27 | Suzanne Blaug, age 65, joined the Board in June 2019. ... We believe Ms. Blaug is qualified to serve on the Board based on her vast commercial and strategic experience in the pharmaceutical industry. ... Our Compensation Committee consists of Ms. Blaug, Dr. Brennan, and Mr. Lema. ... Our Nominating and Corporate Governance Committee consists of Messrs. Schoeneck and Henderson, Ms. Blaug, and Dr. Cravatt. ... The following table sets forth information regarding compensation earned by or paid to our non-employee directors during fiscal year 2022: ... Suzanne Blaug $356,954 ... |
| 2024-04-24 | Suzanne Blaug, age 66, joined the Board in June 2019. Ms. Blaug serves on Audit, Compensation, and Nominating and Corporate Governance Committees. Director compensation table shows total $388,034. |
Data sourced from SEC filings. Last updated: 2026-02-03